🔗 Share this article Social Media Content Creators Fueling Parallel Market for Unlicensed Slimming Medication An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations. Investigational Treatment Acquiring Traction Online Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers. Active Trade on Messaging Platforms Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for purchases. Understanding The Experimental Drug This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic. Healthcare Experts Voice Concerns Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting products of uncertain source. Some experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro. Regulatory Status and Implementation Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012. Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, risking penalties, prosecution or prison. Service Response and Material Removal Based on the social media company, the service has removed problematic content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures. Online Trading Activities Research also discovered communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, populated with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at residence. Within moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage. Item Details and Costs Inside these communities, posts display dark colored packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”. Platform Moderation and Safety Measures A spokesperson for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”. Medical Expert Cautions “People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained. Her staff has already seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.” Manufacturer Position A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially serious health risks”.